Terazosin (Hytrin)

DRUG3 trials

Sponsors

Hospital Authority, Hong Kong, University College, London, Qiang Zhang

Conditions

Alzheimer s DiseaseParkinsons Disease (PD)Prostatic HyperplasiaUrinary Retention

Phase 2

Terazosin And Metabolic Engagement in Alzheimer's Disease

Not yet recruitingNCT07796308

Qiang ZhangAlzheimer s Disease

Start: 2027-08-01End: 2032-07-31Target: 100Updated: 2026-09-01

Phase 3

Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial

RecruitingNCT07207057

University College, LondonParkinsons Disease (PD)

Start: 2025-09-12End: 2031-07-31Target: 1200Updated: 2025-10-03

Unknown Phase

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

TerminatedNCT00563485

Hospital Authority, Hong KongProstatic Hyperplasia, Urinary Retention

Start: 2005-10-31End: 2006-11-30Target: 120Updated: 2011-06-16